Article
Targeting the BAF complex in advanced prostate cancer.
Expert opinion on drug discovery - 1 Feb 2021
Hartley Andrew, Leung Hing Y, Ahmad Imran
Abstract excerpt
INTRODUCTION: The BRG1/BRM associated factors (BAF) complex is a chromatin remodeling SWI/SNF which is mutated in 20% of cancers. This complex has many interchangeable subunits which may have oncogenic or tumor suppressor activity in a context-dependent manner. The BAF complex is mutated in 35-50% of metastatic prostate cancer (PC); however, its role in advanced disease is unclear. This review attempts to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
